Livestock Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Livestock Pharmaceuticals Market: Based on the Drug Class (Vaccines, Antivirals, Antibiotics, Parasiticides, Anti-inflammatory drugs, Others), Based on the Disease Type (Neurological disorders, Infectious diseases, Viral diseases, Bacterial diseases, Fungal diseases, Others), Based on the Route Of Administration (Oral, Parenteral, Topical, Others), Based on the Livestock (Poultry, Aquatic Animals, Swine, Equine, Sheep, Cattle, Others), Based on the Distribution Channel (Veterinary hospitals, Veterinary pharmacies, Online pharmacies),and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Livestock pharmaceuticals market is used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed. Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

Livestock Pharmaceuticals Market

MARKET SUMMARY
-
x%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– x%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Livestock Pharmaceuticals Market

  • The report on global livestock pharmaceuticals market gives historical, current and future market sizes (US$ Bn) based on by product type, by product type, by end-user and region.
  • livestock pharmaceuticals market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Merck Animal Health
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Bayer Animal Health
  • Virbac Inc.
  • Heska Corporation
Livestock Pharmaceuticals Market

Drivers And Restraints

Increase in the prevalence of various livestock diseases such as bird flu in poultry, rise in animal welfare expenditure, government initiatives for the animal health management, and rise in demand for healthy meat and other livestock products are anticipated to fuel the livestock pharmaceuticals market. Moreover, rise in disposable income, increase in the awareness about livestock diseases and treatment, and rise in R&D activities for the innovation of newer therapeutics and vaccines might bolster the growth of the market. However, stringent regulatory guidelines for veterinary medicine approval, ban of certain antibiotics used in the animal diseases, poor availability of drugs in the underdeveloped regions, and dearth of skilled veterinary professionals are hampering the growth of the market.


North-America got significant share

Livestock Pharmaceuticals Market

Geographically, livestock pharmaceuticals market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Increase in the R&D activities for the development of newer drugs by several U.S. pharmaceutical companies, rise in awareness about the veterinary diseases and treatment, increase in the animal welfare expenditure, and rise in product approvals for livestock diseases are anticipated to propel the North America livestock pharmaceuticals market. Europe livestock pharmaceuticals market growth driven by rise in the production of aquatic animals in Norway, Denmark, Ireland, and other European countries, increase in the demand for healthy meat and other livestock products, rise in the disposable income, and increase in the prevalence of zoonotic diseases. However, Asia Pacific livestock pharmaceuticals market growing at significant rate owing to increase in population demanding for quality meat, launching of newer drugs in Asia Pacific region, and industrialization of poultry sector in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In July 2017, ECO Animal Health received FDA approval for Aivlosin an antibiotic used in the treatment of major enteric and respiratory diseases in poultry and swine
  • In March 2017, Merck Animal Health acquired Brazilian company Vallee S.A. for strengthening its livestock pharmaceuticals product portfolio

Key

Key Features of the Report

Livestock Pharmaceuticals Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Executive Summary
2. Global Livestock Pharmaceuticals Market Introduction
2.1. Global Livestock Pharmaceuticals Market – Taxonomy
2.2. Global Livestock Pharmaceuticals Market –Definitions
2.2.1. Drug Class
2.2.2. Disease Type
2.2.3. Route of administration
2.2.4. Livestock
2.2.5. Distribution Channel
3. Global Livestock Pharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Livestock Pharmaceuticals Market Dynamic Factors – Impact Analysis
3.6. Global Livestock Pharmaceuticals Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Livestock Pharmaceuticals Market – Recent Product Introductions
4. Global Livestock Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Livestock Pharmaceuticals Market, By Drug Class, 2015 – 2019 and Forecast, 2020 – 2026
5.1. Vaccines
5.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Antivirals
5.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Antibiotics
5.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Parasiticides
5.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Anti-Inflammatory Drugs
5.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Livestock Pharmaceuticals Market, By Disease Type, 2015 – 2019 and Forecast, 2020 – 2026
6.1. Neurological Disease
6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Infectious Diseases
6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Viral Diseases
6.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Bacterial Diseases
6.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Fungal Diseases
6.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Livestock Pharmaceuticals Market Forecast, By Route of Administration, 2015 – 2019 and Forecast, 2020 – 2026
7.1. Oral
7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Parenteral
7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Topical
7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Livestock Pharmaceuticals Market Forecast, By Livestock, 2015 – 2019 and Forecast, 2020 – 2026
8.1. Poultry
8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Swine
8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Aquatic Animals
8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Cattle
8.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Equine
8.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Pet Animals
8.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.6.3. Market Opportunity Analysis
9. Global Livestock Pharmaceuticals Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026
9.1. Veterinary Pharmacies
9.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Veterinary Clinics
9.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Online Pharmacies
9.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 20264 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
10. Global Livestock Pharmaceuticals Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026
10.1. North America
10.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Drug Class, By Diseases Type, By Route of Administration, By Animal, By Distribution Channel and Region, 2020 – 2026
11. North America Livestock Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
11.1. Drug Class 2015 – 2019 and Forecast, 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Vaccines
11.1.2. Antivirals
11.1.3. Antibiotics
11.1.4. Parasiticides
11.1.5. Anti-Inflammatory drugs
11.1.6. Others
11.2. Disease Type Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Neurological Disorders
11.2.2. Infectious Diseases
11.2.3. Viral Diseases
11.2.4. Bacterial Diseases
11.2.5. Fungal Diseases
11.2.6. Others
11.3. Route of Administration Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Parenteral
11.3.3. Topical
11.3.4. Others
11.4. Animal Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.4.1. Poultry
11.4.2. Swine
11.4.3. Aquatic Animals
11.4.4. Cattle
11.4.5. Equine
11.4.6. Pet Animals
11.4.7. Others
11.5. Distribution Channel Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.5.1. Veterinary Pharmacies
11.5.2. Veterinary Clinics
11.5.3. Online Pharmacies
11.6. Country Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. U.S.
11.6.2. Canada
11.7. North America Livestock Pharmaceuticals Market – Opportunity Analysis Index By Drug Class, By Diseases Type, By Route of Administration, By Animal, By Distribution Channel and Country, 2020 – 2026
11.8. North America Livestock Pharmaceuticals Market Dynamics – Trends
12. Europe Livestock Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
12.1. Drug Class Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Vaccines
12.1.2. Antivirals
12.1.3. Antibiotics
12.1.4. Parasiticides
12.1.5. Anti-Inflammatory drugs
12.1.6. Others
12.2. Disease Type Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Neurological Disorders
12.2.2. Infectious Diseases
12.2.3. Viral Diseases
12.2.4. Bacterial Diseases
12.2.5. Fungal Diseases
12.2.6. Others
12.3. Route of Administration Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Parenteral
12.3.3. Topical
12.3.4. Others
12.4. Animal Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.4.1. Poultry
12.4.2. Swine
12.4.3. Aquatic Animals
12.4.4. Cattle
12.4.5. Equine
12.4.6. Pet Animals
12.4.7. Others
12.5. Distribution Channel Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.5.1. Veterinary Pharmacies
12.5.2. Veterinary Clinics
12.5.3. Online Pharmacies
12.6. Country Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Poland
12.6.8. Rest of Europe
12.7. Europe Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Drug Class, By Diseases Type, By Route of Administration, By Animal, By Distribution Channel and Country, 2020 – 2026
12.8. Europe Livestock Pharmaceuticals Market Dynamics – Trends
13. Asia-Pacific Livestock Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
13.1. Drug Class Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Vaccines
13.1.2. Antivirals
13.1.3. Antibiotics
13.1.4. Parasiticides
13.1.5. Anti-Inflammatory drugs
13.1.6. Others
13.2. Disease Type Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Neurological Disorders
13.2.2. Infectious Diseases
13.2.3. Viral Diseases
13.2.4. Bacterial Diseases
13.2.5. Fungal Diseases
13.2.6. Others
13.3. Route of Administration Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Parenteral
13.3.3. Topical
13.3.4. Others
13.4. Animal Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.4.1. Poultry
13.4.2. Swine
13.4.3. Aquatic Animals
13.4.4. Cattle
13.4.5. Equine
13.4.6. Pet Animals
13.4.7. Others
13.5. Distribution Channel Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.5.1. Veterinary Pharmacies
13.5.2. Veterinary Clinics
13.5.3. Online Pharmacies
13.6. Country Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Drug Class, By Diseases Type, By Route of Administration, By Animal, By Distribution Channel and Country, 2020 – 2026
13.8. Asia-Pacific Livestock Pharmaceuticals Market Dynamics – Trends
14. Latin America Livestock Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
14.1. Drug Class Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Vaccines
14.1.2. Antivirals
14.1.3. Antibiotics
14.1.4. Parasiticides
14.1.5. Anti-Inflammatory drugs
14.1.6. Others
14.2. Disease Type Analysis 2019 and Forecast (2020– 2026)by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Neurological Disorders
14.2.2. Infectious Diseases
14.2.3. Viral Diseases
14.2.4. Bacterial Diseases
14.2.5. Fungal Diseases
14.2.6. Others
14.3. Route of Administration Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Parenteral
14.3.3. Topical
14.3.4. Others
14.4. Animal Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.4.1. Poultry
14.4.2. Swine
14.4.3. Aquatic Animals
14.4.4. Cattle
14.4.5. Equine
14.4.6. Pet Animals
14.4.7. Others
14.5. Distribution Channel Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Veterinary Pharmacies
14.5.2. Veterinary Clinics
14.5.3. Online Pharmacies
14.6. Country Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Venezuela
14.6.5. Rest of Latin America
14.7. Latin America Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Drug Class, By Diseases Type, By Route of Administration, By Animal, By Distribution Channel and Country, 2020 – 2026
14.8. Latin America Livestock Pharmaceuticals Market Dynamics – Trends
15. Middle East and Africa Livestock Pharmaceuticals Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
15.1. Drug Class Analysis 2019 and Forecast (2020– 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Vaccines
15.1.2. Antivirals
15.1.3. Antibiotics
15.1.4. Parasiticides
15.1.5. Anti-Inflammatory drugs
15.1.6. Others
15.2. Disease Type Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. Neurological Disorders
15.2.2. Infectious Diseases
15.2.3. Viral Diseases
15.2.4. Bacterial Diseases
15.2.5. Fungal Diseases
15.2.6. Others
15.3. Route of Administration Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Oral
15.3.2. Parenteral
15.3.3. Topical
15.3.4. Others
15.4. Animal Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.4.1. Poultry
15.4.2. Swine
15.4.3. Aquatic Animals
15.4.4. Cattle
15.4.5. Equine
15.4.6. Pet Animals
15.4.7. Others
15.5. Distribution Channel Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
15.5.1. Veterinary Pharmacies
15.5.2. Veterinary Clinics
15.5.3. Online Pharmacies
15.6. Country Analysis 2019 and Forecast (2020 – 2026)by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Livestock Pharmaceuticals Market – Opportunity Analysis Index, By Drug Class, By Diseases Type, By Route of Administration, By Animal, By Distribution Channel and Country, 2020 – 2026
15.8. MEA Livestock Pharmaceuticals Market Dynamics – Trends
16. Competition Landscape
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Merck Animal Health (U.S.)
16.2.2. Zoetis Inc. (Pfizer) (U.S.)
16.2.3. Boehringer Ingelheim (Germany)
16.2.4. Ceva Animal Health (France)
16.2.5. Bayer Animal Health (Germany)
16.2.6. Virbac Inc. (France)
16.2.7. Elanco Animal Health (U.S.)
16.2.8. Eco Animal Health (U.K.)
16.2.9. Heska Corporation (U.S.)
17. Research Methodology
18. Key Assumptions and Acronyms


Report

Company Profile

  • Merck Animal Health (U.S.)
  • Zoetis Inc. (Pfizer) (U.S.)
  • Boehringer Ingelheim (Germany)
  • Ceva Animal Health (France)
  • Bayer Animal Health (Germany)
  • Virbac Inc. (France)
  • Elanco Animal Health (U.S.)
  • Eco Animal Health (U.K.)
  • Heska Corporation (U.S.)

Description

Livestock pharmaceuticals market is used to treat various diseases in animals such as infectious diseases, parasitic diseases, and inflammatory diseases among others. Vaccines are administered to livestock for the prevention of various diseases which increase the immunity of the livestock and makes animal healthy. Livestock pharmaceuticals can be administered as solids or liquids directly to the livestock or some pharmaceuticals can be mixed with the animal feed. Livestock pharmaceuticals market growing at a significant CAGR owing to increase in the R&D activities for the innovation of newer drugs for various livestock diseases. Increase in the prevalence of various livestock diseases, rise in demand for healthy meat and other livestock products, increase in the farming of aquatic animals might propel the livestock pharmaceuticals market over the forecast period. Acquisitions & mergers, collaborations, and product launching are the strategies followed by the companies for increasing their revenue share in livestock pharmaceuticals market. For instance, in November 2014, Merck Animal Health launched Finadyne a transdermal non-steroidal anti-inflammatory drug used in cattle for the treatment of pyrexia associated with bovine respiratory disease. In addition, in March 2016, Zoetis Inc. inked an agreement with Sanofi’s Merial unit for diversifying the product portfolio and marketing the vaccines and drugs for dairy cattle in India.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX